Analystreport

Esperion Therapeutics Inc (NASDAQ: ESPR) had its "hold" rating re-affirmed by analysts at Northland Securities. They now have a $42.00 price target on the stock.

Esperion Therapeutics, Inc.  (ESPR) 
Last esperion therapeutics, inc. earnings: 2/27 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.esperion.com